Hormel Foods announced preliminary adjusted earnings projections for Q1 2026 that exceeded analyst estimates. Concurrently, the company has entered a definitive agreement to sell its Minnesota turkey assets, which include its whole-bird turkey business, to Life-Science Innovations. This strategic move aligns with Hormel’s portfolio management and financial performance expectations.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hormel Foods' Preliminary Q1 Adjusted Earnings Projections Beat Estimates; Sells Minnesota Turkey Assets to Life-Science Innovations
Hormel Foods announced preliminary adjusted earnings projections for Q1 2026 that exceeded analyst estimates. Concurrently, the company has entered a definitive agreement to sell its Minnesota turkey assets, which include its whole-bird turkey business, to Life-Science Innovations. This strategic move aligns with Hormel’s portfolio management and financial performance expectations.